Abstract: An electronic display may include a touch sensing system configured to perform touch sensing in an active area of the electronic display and display driver circuitry configured to program display pixels of the active area to emit light. The electronic display may also include the active area. The active area may include a first portion and a second portion that are at least partially electrically separated. The display driver circuitry may program the display pixels in the first portion while the touch sensing circuitry may perform touch sensing in the second portion.

Abstract: A thermal insulation cabinet and a manufacturing method therefor, and a refrigerator having same. The manufacturing method for the thermal insulation cabinet comprises the following steps: pre-assembling a shell having a vacuum insulation panel attached to the inside, into a cabinet shell; heating the inside of the cabinet shell; and injecting a foaming material between the cabinet shell and an inner liner for foaming. According to the present invention, the inside of the cabinet shell is heated, such that the inner surface of the shell can reach a target temperature required for foaming, thereby reducing or avoiding a surface crusting phenomenon, and improving a thermal insulation effect of the thermal insulation cabinet.

Abstract: The disclosure provides new transmucosal and subcutaneous pharmaceutical compositions comprising 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or 1-(4-fluoro-phenyl)-4-((6bR,10aS)-2,2-d2-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one or comprising -(4-fluoro-phenyl)-4-((6bR,10aS)-1,1,2,2-d4-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, in free base, co-crystal or salt form, together with methods of making and using them.

Abstract: The present disclosure provides a hollow-core microstructure optical fiber preform, an optical fiber, and a method for manufacturing thereof. An objective of the present disclosure is to introduce a support sheet into a nested structure unit of the hollow-core microstructure optical fiber preform, which not only increases the number of reflection surfaces without increasing the number of nested layers of glass tubes, but also achieves a more accurate positioning by the support sheet and improves manufacturing accuracy as compared to a tangential structure of nested glass tubes, such that the following technical problems, difficulty in controlling a curvature of reflection surfaces, low manufacturing accuracy, large difference between actual loss and theoretical loss, or poor batch consistency, in related anti-resonance optical fibers, caused by increasing the number of layers of nested microstructure units in order to increase the number of reflection surfaces, are solved.

Abstract: A method performed by a function in a network node in a telecommunications network having at least one service communication proxy, SCP, deployed between a first network node and a second network node. The method includes receiving a request for routing information to signal a message from the first network node to the second network node. The method further includes responsive to the request from the first network node, providing a response to a network node that sent the request wherein the response identifies at least a portion of a routing path for the message based on a routing path configuration.

Abstract: The disclosure provides new, stable, pharmaceutically acceptable amorphous solid dispersions of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.

Abstract: A system may include a memory and a processor in communication with the memory. The processor may be configured to perform operations. The operations may include registering a custom resource definition for a tenant with a host and scaling a controller for the customer resource definition. The operations may include generating a replication using the customer resource definition, injecting information into the replication, and syncing a status of the custom resource definition between the host and the tenant.

Abstract: A system may include a memory and a processor in communication with the memory. The processor may be configured to perform operations. The operations may include introducing a migration controller to an open-source container environment and assessing the open-source container environment for duplicative services. The operations may include selecting a shared service and a duplicated service from the duplicative services and redirecting resource requests through the migration controller to the shared service. The operations may include terminating the duplicated service.

Abstract: The disclosure provides methods, treatments and materials for treating diseases or disorders mediated by cyclic nucleotides and/or sodium glucose cotransporter 2. In particular, the present disclosure provides for methods of treating such diseases and disorders with a PDE1 inhibitor in combination with additional therapeutic agents.

Abstract: A fluid splitter, a fluid end, and a plunger pump are provided. The fluid splitter includes: a body having a shape of column and including a first end, a second end, and a side surface connecting the first end and the second end; a first opening, located at the side surface of the body; a first cavity, located at the first end; a first channel, communicated with the first opening and the first cavity, respectively, the first channel extending from the first opening to the first cavity and being configured to allow fluid to flow therethrough; a second opening, located at the side surface of the body; a second cavity, located at the second end; and a second channel, communicated with the second opening and the second cavity, respectively, the second channel extending from the second opening to the second cavity and being configured to allow fluid to flow therethrough.

Abstract: The present disclosure belongs to the technical field of ultrasonic non-destructive testing, and discloses a method for extracting feature path signals of pipeline ultrasonic helical guided waves. The method includes: transforming a nonlinear wave number relationship of a pipe wall into a linear form by first order Taylor expansion, the approximation being reasonable under narrow band excitation; on this basis, establishing multimodal and multipath guided wave propagation over-complete data sets, and obtaining a modal weight factor and a path weight factor through a single-layer neural network algorithm; and multiplying the modal weight factor by the multimodal data set to separate a plurality of groups of unimodal signals from a whole signal, and multiplying the path weight factor by the multipath data set to extract unimodal feature path signals. The present disclosure can effectively extract unimodal unipath guided wave feature signals and improve the signal identification, and has broad prospects.

Abstract: The disclosure provides new, stable, pharmaceutically acceptable amorphous solid dispersions of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3?,4?:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.

Abstract: A method and device for determining a suction height of a variable speed unit is provided. The method includes: acquiring a reference cavitation coefficient and a reference specific rotation speed parameter corresponding to a target water head section in a preset number of power stations; conducting calculations on the reference cavitation coefficient and the reference specific rotation speed parameter by utilizing a target scheme to obtain a target formula; acquiring a maximum lift, a minimum lift, a speed variation range and a synchronous rotation speed value of a current target variable speed unit and input force values of the target variable speed unit at a plurality of key working condition points; and determining a target suction height of the target variable speed unit.

Abstract: The invention relates to pharmaceutical compositions comprising the compound of Formula I, and new methods and uses pertaining thereto, and pharmaceutical compositions thereof, such as methods of use in the treatment of diseases involving the 5-HT receptor, the serotonin transporter (SERT), and/or pathways involving dopamine D2 receptor signaling, sodium channel activity, and/or norepinephrine transporter activity.

Abstract: A computer-implemented method, an apparatus, and a computer program product for edge node autonomy. For a first edge node of a plurality of edge nodes in a federation in a distributed computing framework, one or more processors receive a request to be sent to a central node in the distributed computing framework. The one or more processors determine whether the federation is connected to the central node. In response to determining that the federation is not connected to the central node, the one or more processors determine whether a controller capable of processing the request is available in the federation. In response to determining that the controller capable of processing the request is available in the federation, the one or more processors notify the controller to process the request.

Abstract: Examples herein relate to a storage system that separately handles portions of a write operation that are aligned and misaligned with respect to retrievable segments from a storage device. For misaligned portions, a buffer can be used to store misaligned retrievable segments and update the segments with content provided with the write operation. Aligned portions of content associated with a write request can be written directly to the storage medium or overwrite corresponding retrievable segments present in the buffer. A table or array can track logical block addresses that correspond to content in the buffer or in the storage. Content in the buffer can be kept in the buffer without being backed-up or persisted to the storage until a triggering event occurs such as power loss or low space in the buffer.

Abstract: The present disclosure provides a method for extracting and recovering gold from an aqueous solution, the method including: (1) gold extraction from an aqueous solution through electrocoagulation, in which an electrocoagulation reaction is performed in an electrolytic cell to produce iron hydroxide in-situ, so as to capture gold in the aqueous solution and reduces the gold into gold nanoparticles in-situ; (2) pickling and liquefaction of the precipitated iron sludge, in which the obtained precipitate is dissolved in nitric acid to dissolve iron flocs after washing treatment; and (3) separation and recovery of gold through a nanofiltration membrane system, in which the resulting solution after pickling the precipitated iron sludge is subjected to cut-off treatment using a nanofiltration membrane to separate nano-sized elemental gold from the solution, and then the resultant is washed with water to obtain elemental gold.

Abstract: Disclosed are a computer-implemented method, a device and a computer program product of node management for a cluster of a cluster of computing nodes. A plurality of computing nodes in a cluster can be grouped into a hierarchy of groups according to a hierarchy of grouping policies. One of computing nodes in each group of the hierarchy of groups can be determined as a leader node of the corresponding group. A leader node of a first group can be responsible for collecting and reporting status of all computing nodes in the first group to a leader node of a second group superior to the first group by one level in the hierarchy of groups.

Abstract: The invention relates to particular substituted (3?,5?-3-hydroxy-pregnan-20-ones, in free or pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use as sedatives, hypnotics, anxiolytics, and/or anesthetics, and methods for treatment of depression, anxiety, insomnia, epilepsy, and other central nervous system disorders, as well as to combinations with other agents.